Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Veerman

Showing results (871-880 of 941) with videos related to

Pageof 95
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 20, 2022
Influence of esomeprazole on the bioavailability of afatinib: A pharmacokinetic cross-over study in patients with non-small cell lung cancerG D Marijn Veerman, Daan P Hurkmans, Marthe S Paats, et al.
Journal of Medicinal Chemistry|March 18, 2005
Bioisosteric replacements of the pyrazole moiety of rimonabant: synthesis, biological properties, and molecular modeling investigations of thiazoles, triazoles, and imidazoles as potent and selective CB1 cannabinoid receptor antagonistsJos H M Lange, Herman H van Stuivenberg, Hein K A C Coolen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 25, 2005
Chewing gum and a saliva substitute alleviate thirst and xerostomia in patients on haemodialysisCasper P Bots, Henk S Brand, Enno C I Veerman, et al.
Leukemia|May 7, 2010
IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALLR P Kuiper, E Waanders, V H J van der Velden, et al.
Leukemia|September 24, 2010
NOTCH1 and/or FBXW7 mutations predict for initial good prednisone response but not for improved outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on DCOG or COALL protocolsL Zuurbier, I Homminga, V Calvert, et al.
The Journal of Biological Chemistry|September 10, 2004
Bacteria binding by DMBT1/SAG/gp-340 is confined to the VEVLXXXXW motif in its scavenger receptor cysteine-rich domainsFloris J Bikker, Antoon J M Ligtenberg, Caroline End, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 31, 2023
Analysis of Serious Weight Gain in Patients Using Alectinib for ALK-Positive Lung CancerSimon P de Leeuw, Melinda A Pruis, Barend J Sikkema, et al.
Leukemia|November 25, 2010
Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemiaE Waanders, V H J van der Velden, C E van der Schoot, et al.
Leukemia|January 9, 2004
In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotypeN L Ramakers-van Woerden, H B Beverloo, A J P Veerman, et al.
The Journal of Pediatrics|June 6, 2000
Clinical and virologic response to combination treatment with indinavir, zidovudine, and lamivudine in children with human immunodeficiency virus-1 infection: a multicenter study in the Netherlands. On behalf of the Dutch Study Group for Children with HIV-1 infectionsA M van Rossum, H G Niesters, S P Geelen, et al.
Pageof 95

Showing results (871-880 of 941) with videos related to

Sort By:
Pageof 95
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 20, 2022
Influence of esomeprazole on the bioavailability of afatinib: A pharmacokinetic cross-over study in patients with non-small cell lung cancerG D Marijn Veerman, Daan P Hurkmans, Marthe S Paats, et al.
Journal of Medicinal Chemistry|March 18, 2005
Bioisosteric replacements of the pyrazole moiety of rimonabant: synthesis, biological properties, and molecular modeling investigations of thiazoles, triazoles, and imidazoles as potent and selective CB1 cannabinoid receptor antagonistsJos H M Lange, Herman H van Stuivenberg, Hein K A C Coolen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 25, 2005
Chewing gum and a saliva substitute alleviate thirst and xerostomia in patients on haemodialysisCasper P Bots, Henk S Brand, Enno C I Veerman, et al.
Leukemia|May 7, 2010
IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALLR P Kuiper, E Waanders, V H J van der Velden, et al.
Leukemia|September 24, 2010
NOTCH1 and/or FBXW7 mutations predict for initial good prednisone response but not for improved outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on DCOG or COALL protocolsL Zuurbier, I Homminga, V Calvert, et al.
The Journal of Biological Chemistry|September 10, 2004
Bacteria binding by DMBT1/SAG/gp-340 is confined to the VEVLXXXXW motif in its scavenger receptor cysteine-rich domainsFloris J Bikker, Antoon J M Ligtenberg, Caroline End, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 31, 2023
Analysis of Serious Weight Gain in Patients Using Alectinib for ALK-Positive Lung CancerSimon P de Leeuw, Melinda A Pruis, Barend J Sikkema, et al.
Leukemia|November 25, 2010
Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemiaE Waanders, V H J van der Velden, C E van der Schoot, et al.
Leukemia|January 9, 2004
In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotypeN L Ramakers-van Woerden, H B Beverloo, A J P Veerman, et al.
The Journal of Pediatrics|June 6, 2000
Clinical and virologic response to combination treatment with indinavir, zidovudine, and lamivudine in children with human immunodeficiency virus-1 infection: a multicenter study in the Netherlands. On behalf of the Dutch Study Group for Children with HIV-1 infectionsA M van Rossum, H G Niesters, S P Geelen, et al.
Pageof 95